Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 18/04/20121 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; KEPIVANCE; Correction
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of April 2, 2007 (72 FR 15699). The document concerned FDA's determination of the regulatory review period for KEPIVANCE. The document cited an incorrect statute under which the KEPIVANCE biologics license application was submitted. This document corrects the citation.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →